BORTEZOMIB INJECTION DIN 02566621
Health Canada record
| Active ingredient(s) | BORTEZOMIB 2.5 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous; Subcutaneous |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01XG01 BORTEZOMIB |
| Original market date | |
| Current status date | 16-Mar-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Sterimax Inc — licence 100925, currently licensed, last inspection rating C (2024-05-13).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37116 | 2026-03-16 | Abbreviated New Drug Submission (ANDS) |
International API supply for BORTEZOMIB
23 active FDA Drug Master Files.
Request a quote for BORTEZOMIB INJECTION